Single-Cell Raman Spectroscopy Combined with Metabolomics Reveals Distinct Metabolic Profiles in Medulloblastoma Subtypes
Analytical Chemistry · 2025
DOI: 10.1021/acs.analchem.5c02816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Yijia Peng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute for Pediatric Research, Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Xin Hua Hospital, Shanghai Jiao Tong …. Hauptthemen laut MEDLINE: Medulloblastoma, Spectrum Analysis, Raman, Single-Cell Analysis, Metabolomics. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor heterogeneity poses a major challenge to the precision treatment of medulloblastoma (MB). Rapid and accurate subtyping tools are urgently needed for informed clinical decision-making. Herein, we demonstrate the utility of Raman spectroscopy (RS) as a label-free, noninvasive approach for molecular characterization and subtype discrimination of MB at the single-cell level. Five representative MB cell lines from group 3 and sonic hedgehog (SHH) subtypes, along with microglial controls, were profiled by RS and validated using mass spectrometry-based metabolomics. RS-derived single-cell metabolic fingerprints revealed subtype-specific variations in nucleic acids, amino acids, lipids, and proteins. Group 3 cells, exemplified by metastatic D283, exhibited elevated levels of unsaturated lipids compared with most SHH cells. Notably, Daoy cells from the SHH subtype displayed unsaturation levels comparable to D283, reflecting intragroup heterogeneity and membrane remodeling in MB. Machine learning classifiers achieved high diagnostic performance, with an average area under the curve of 0.994 and a Matthews correlation coefficient of 0.935. Furthermore, cisplatin-treated D283 cells showed increased unsaturated lipid content relative to Daoy cells, revealing subtype-dependent metabolic shifts in drug response. These findings underscore the metabolic diversity of MB subtypes and the role of lipid metabolism in tumor progression and therapy. Collectively, our results exemplify the power of RS combined with metabolomics for molecule-resolved, label-free MB subtyping and therapeutic stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shanghai Institute for Pediatric Research, Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
- Department of Chemistry, Fudan University, Shanghai 200433, China.
ORCID-Profile: Baohong Liu, Kun Zhang
Förderung
- Natural Science Foundation of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Peng, Y., Li, M., Liu, Y., Zhang, R., Liu, B., & Zhang, K. (2025). Single-Cell Raman Spectroscopy Combined with Metabolomics Reveals Distinct Metabolic Profiles in Medulloblastoma Subtypes. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c02816
Vancouver
Peng Y, Li M, Liu Y, Zhang R, Liu B, Zhang K. Single-Cell Raman Spectroscopy Combined with Metabolomics Reveals Distinct Metabolic Profiles in Medulloblastoma Subtypes. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.5c02816
BibTeX
@article{Peng2025,
author = {Peng, Yijia and Li, Minghui and Liu, Yujie and Zhang, Ren and Liu, Baohong and Zhang, Kun},
title = {Single-Cell Raman Spectroscopy Combined with Metabolomics Reveals Distinct Metabolic Profiles in Medulloblastoma Subtypes},
journal = {Analytical Chemistry},
year = {2025},
doi = {10.1021/acs.analchem.5c02816}
}
EUVIMED